Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts.
about
Theranostic applications of antibodies in oncology.Antibody-based imaging of HER-2: moving into the clinic.Model-based analysis of HER activation in cells co-expressing EGFR, HER2 and HER3'Image and treat': an individualized approach to urological tumorsIn vivo targeting of HER2-positive tumor using 2-helix affibody molecules.Quantitating antibody uptake in vivo: conditional dependence on antigen expression levels.Evaluation of (89)Zr-pertuzumab in Breast cancer xenografts.Evaluation of the anti-HER2 C6.5 diabody as a PET radiotracer to monitor HER2 status and predict response to trastuzumab treatmentD-Amino acid peptide residualizing agents bearing N-hydroxysuccinimido- and maleimido-functional groups and their application for trastuzumab radioiodinationA comparison of 111In- or 64Cu-DOTA-trastuzumab Fab fragments for imaging subcutaneous HER2-positive tumor xenografts in athymic mice using microSPECT/CT or microPET/CT.Molecular imaging of HER2-positive breast cancer: a step toward an individualized 'image and treat' strategy.Molecular imaging probes for diagnosis and therapy evaluation of breast cancerDevelopments in single photon emission computed tomography and PET-based HER2 molecular imaging for breast cancer.General overview of radioimmunotherapy of solid tumors.Imaging EGFR and HER2 by PET and SPECT: a review.Antibodies directed against receptor tyrosine kinases: current and future strategies to fight cancer.Development and preclinical studies of 64Cu-NOTA-pertuzumab F(ab')2 for imaging changes in tumor HER2 expression associated with response to trastuzumab by PET/CT.Performance evaluation of small-animal multipinhole μSPECT scanners for mouse imaging.Review of quantitative multiscale imaging of breast cancer.Radiolabeled pertuzumab for imaging of human epidermal growth factor receptor 2 expression in ovarian cancer.
P2860
Q27693293-5A76F24A-C9D6-4A6B-98B4-EA408F065056Q30423880-F4B2043F-07ED-4190-B206-097002DEF85BQ31129446-4165C214-DFC8-4446-9123-4DA63394254CQ33792596-507EAFFF-28CC-4EE8-BBB1-154BB686059BQ34231627-F20A634C-2669-4916-B72E-DEBFDFF38413Q34400470-69E417DC-7108-4B68-B4A9-DE69AEAB8114Q34473478-6DB68B75-917D-486A-A89F-C617C0E87286Q34694211-9C5597C0-1D62-4955-8669-458FF9595090Q34718122-38A8B6E6-647C-40AE-92A4-760905F5BD97Q35650526-E7D59DD4-B3BA-4B93-9C86-91EEF9452277Q36105964-5AAED5FD-05B9-4145-B327-F3043AAF1641Q36692448-21BD9FCC-4E0D-441C-864F-235E99DF4F71Q38088005-0AA54DA4-7ADC-4B14-A34D-FC934994F198Q38103579-5B9BA916-5107-435E-8A3C-110D8E48DACFQ38137829-CAE21551-D866-481B-8430-FA7A82A23A9FQ38214511-DE898262-CC50-4AD5-B157-F66824FC3B45Q43019940-5B7A7649-40A2-4768-9CE8-2FCF0D3BEC1FQ46109699-728042C0-2239-4BE2-A330-2D65CF9B5379Q48119396-490DD641-FA6F-4E9E-9D24-1F185E6A1445Q50975813-825840AC-D975-4455-838C-A2D7DDBDF4EA
P2860
Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Micro-SPECT/CT with 111In-DTPA ...... uman breast cancer xenografts.
@en
Micro-SPECT/CT with 111In-DTPA ...... uman breast cancer xenografts.
@nl
type
label
Micro-SPECT/CT with 111In-DTPA ...... uman breast cancer xenografts.
@en
Micro-SPECT/CT with 111In-DTPA ...... uman breast cancer xenografts.
@nl
prefLabel
Micro-SPECT/CT with 111In-DTPA ...... uman breast cancer xenografts.
@en
Micro-SPECT/CT with 111In-DTPA ...... uman breast cancer xenografts.
@nl
P2093
P1476
Micro-SPECT/CT with 111In-DTPA ...... uman breast cancer xenografts.
@en
P2093
Bart Cornelissen
Danny L Costantini
Deborah A Scollard
Kristin McLarty
Raymond M Reilly
Susan J Done
Zhongli Cai
P304
P356
10.2967/JNUMED.109.062224
P407
P577
2009-07-17T00:00:00Z